We all want the best for our children. While the thought of enrolling your child in a clinical trial may sound scary, but there are plenty of benefits to trial participation. Some of these benefits include diagnosing, preventing, treating, and sometimes even curing childhood diseases. However, there are some potential risks to trial participation, too. Here’s everything you need to know about enrolling your child in a clinical trial.
What is a Clinical Trial?
Clinical trials are studies with volunteers that help researchers learn how to slow, manage, and treat different diseases. There are different kinds of clinical trials with different intended purposes. There are also four phases of clinical trials that each help scientists answer different ...
Rapamycin is a medication approved by the US Food and Drug Administration as an immunosuppressant drug, making it helpful in preventing rejection in organ transplantation. The medication has also been tested in prior studies — like clinical trials, which help researchers learn how to better slow, manage, and treat diseases — as a treatment for cancer and to evaluate its effects on physical and cognitive function and immune health. Now, researchers at UT Health San Antonio are recruiting participants for a study to evaluate Rapamycin’s effects on heart function, heart muscle stiffening, and circulation. Participants will be compensated up to $300 for study completion, which involves five study visits over the course of about two months.
Who Can Participate in the Rapamycin ...
Clinical trials are the most safe, rigorous way of testing for new and more effective disease treatments. Although Latinos comprise 18.9% of the US population, they make up just 10% of participants in clinical trials run by the National Cancer Institute and 4% of drug trials run by the FDA. This massive underrepresentation of Latinos in clinical trials makes it hard for researchers to develop new treatments for this group, which suffers a heavy burden of cancer, Alzheimer’s, and other diseases. Further, diseases present differently in Latinos than White populations – who traditionally make up most clinical trial participants. For example, Latinos on average present symptoms of Alzheimer’s approximately seven years earlier than other racial and ethnic groups, and are ...
How does COVID-19 affect the brain? Researchers at the Biggs Institute for Alzheimer’s & Neurodegenerative Diseases at UT Health San Antonio are looking for the answer and need your help. Volunteer for the 7T MRI Study of How COVID-19 Affects the Brain! Study volunteers will get an advanced state-of-the-art MRI scan to compare brain imaging of those recovered from COVID-19 to those who have never tested positive for the infection. “This study is to identify the long-term neurological and psychiatric effects of a COVID-19 infection,” according to the Biggs Institute study team, including Drs. Mitzi Gonzales, Gabriel de Erausquin, Sudha Seshadri, Monica Goss, and Mohamed Habes. To volunteer for the 7T MRI Study, contact Vibhuti Patel (210-450-7186), Erin ...
When asked about achievements in her life, Diana Lopez of San Antonio, Texas, didn’t have to think long about her answer. Surviving cancer. Lopez was diagnosed with breast cancer at age 42. Like many of those who are diagnosed, it was a shock to Lopez and her loved ones. “At the time I was scared because you think, they tell you, ‘You have cancer’ and you are like, ‘I’m going to die,’” Lopez said. With the help of a clinical trial – a study with volunteers that helps researchers learn how to slow, manage, and treat diseases like cancer –Lopez stayed strong and continued to fight, no matter the obstacle.
A Cancer Diagnosis and its Impact
Lopez discovered a lump on her breast. At first, she thought nothing of it. “I wasn’t hurting or anything. It ...
Cuando se le preguntó sobre los logros en su vida, Diana López de San Antonio, Texas, no tuvo que pensar mucho en su respuesta. Sobrevivir al cáncer. López fue diagnosticada con cáncer de seno a los 42 años. Al igual que muchos de las personas que son diagnosticadas, fue un shock para López y sus seres queridos. "En ese momento tenía miedo porque piensas, te dicen: 'Tienes cáncer' y dices: 'Voy a morir'", dijo López. Con la ayuda de un estudio clínico – un estudio con pacientes que voluntariamente participan y que ayuda a los investigadores a aprender cómo reducir el progreso, controlar y tratar enfermedades como el cáncer – López se mantuvo fuerte y continuó luchando, sin importar el obstáculo.
Un Diagnóstico de Cáncer y su Impacto
López descubrió un ...
Timothy Leech just celebrated his 40th birthday when he got news that changed his life. Timothy was diagnosed with Stage 4 squamous cell carcinoma, a form of skin cancer, in 2014. Doctors told him he had only a short time to live. “I freaked out, for sure. I thought I was going to be gone real quick,” Timothy said. But, today, eight years later, Timothy is a cancer survivor. He credits his wife, Katie Leech, his medical team, and a clinical trial for getting him to where he is today – not entirely cancer-free but “so small that it’s immeasurable.” A clinical trial is a research study that helps researchers learn more to help slow, manage, and treat diseases like cancer. “It was very much like, this [clinical trial] is the last roll of the dice here,” ...
Timothy Leech acababa de celebrar su cumpleaños número 40, cuando recibió una noticia que cambió su vida. Timothy fue diagnosticado con carcinoma de células escamosas en etapa 4, una forma de cáncer de piel, en 2014. Los médicos le dijeron que le quedaba poco tiempo de vida. “Claro que me asusté, Pensé que me iba a ir muy rápido", dijo Timothy. Pero hoy, ocho años después, Timothy es un sobreviviente de cáncer. Él le da crédito a su esposa, Katie Leech, a su equipo médico y a un estudio clínico por llevarlo a donde está hoy, no completamente libre de cáncer, pero "tan pequeño que no se puede medir". Un estudio clínico es un estudio de investigación que ayuda a los investigadores a aprender más para ayudar a reducir el progreso, controlar y tratar ...
Clinical trials can help researchers learn to better treat asthma – but they need diverse volunteers. Black and Latino children who have severe asthma, are prone to asthma attacks, and live in low-income urban neighborhoods are underrepresented in asthma treatment clinical trials, even though they are more likely than whites to face health inequities that can exacerbate asthma symptoms. Fortunately, a recent National Institutes of Health (NIH)-funded clinical trial with mostly Black and Latino children found that a monoclonal antibody – mepolizumab – can decrease asthma attacks by 27%. Antibodies are made naturally in the body to fight infection. A monoclonal antibody is made in the laboratory and administered to patients to treat a variety of diseases and infections, ...
